HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ABBV
Abbvie Inc
Healthcare Drug Manufacturers - General · Illinois, USA · Reports in usd
Market Cap: $349.39B
Market Cap
$349.39B
Enterprise Val
$411.63B
P/E Ratio
82.68
P/B Ratio
-106.85
Trailing PEG (1Y)
-0.01
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$3.23B
Gross Margin72.61%
Profit Margin72.61%
Return on Equity-361.58%
Return on Assets3.12%
Current Ratio0.67
Debt/Equity-20.64
LT Debt/Equity-18.02
Revenue Per Share9.40

Income Statement

Dec 31, 2025
Revenue$16.62B
Cost of Revenue$4.55B
Gross Profit$12.07B
R&D$2.58B
SG&A$3.90B
Operating Expenses$7.52B
Operating Income$4.54B
Interest Expense$655.0M
Tax Expense$853.0M
Net Income$1.82B
EPS (Basic)$1.02
EPS (Diluted)$1.02
EBIT$3.32B
EBITDA$5.31B
Consolidated Income$1.82B
Non-Controlling Interests-$1.0M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$5.23B
Accounts Receivable$12.59B
Inventory$4.95B
Current Assets$29.06B
LT Investments$268.0M
Property, Plant & Equipment$5.63B
Intangibles$88.28B
Non-Current Assets$104.90B
Total Assets$133.96B
Accounts Payable$34.73B
Current Debt$8.56B
Current Liabilities$43.29B
LT Debt$58.94B
Non-Current Liabilities$93.90B
Total Liabilities$137.19B
Total Debt$67.50B
Retained Earnings-$15.49B
Shareholder Equity-$3.27B
Shares Outstanding1,767,384,632

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$5.22B
Investing Cash Flow-$1.46B
Financing Cash Flow-$4.17B
CapEx-$329.0M
Free Cash Flow$4.89B
Depreciation & Amort.$1.99B
Stock-Based Comp$157.0M
Acquisitions / Disposals-$1.16B
Investment Activity$28.0M
Debt Issued/Repaid-$1.30B
Equity Issued/Repaid$45.0M
Dividends Paid-$2.91B
Net Change in Cash-$400.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h